Linked Life Data

16467544

Source:http://linkedlifedata.com/resource/pubmed/id/16467544

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2006-2-9
pubmed:databankReference
pubmed:abstractText
We conducted a multinational, randomized study to compare radiotherapy alone with radiotherapy plus cetuximab, a monoclonal antibody against the epidermal growth factor receptor, in the treatment of locoregionally advanced squamous-cell carcinoma of the head and neck.
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1533-4406
pubmed:author
pubmed:copyrightInfo
Copyright 2006 Massachusetts Medical Society.
pubmed:issnType
Electronic
pubmed:day
9
pubmed:volume
354
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
567-78
pubmed:dateRevised
2011-9-15
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.
pubmed:affiliation
Department of Medicine, University of Alabama, Birmingham, USA.
pubmed:publicationType
Journal Article, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase III, Research Support, N.I.H., Extramural